
COIN Stock Is Undervalued as Coinbase Has ‘Hidden Value’ in Its VC Arm
The market or business model of Coinbase and the stock outlook are highly dependent on the performance of Bitcoin and the broader digital currency ecosystem.
The market or business model of Coinbase and the stock outlook are highly dependent on the performance of Bitcoin and the broader digital currency ecosystem.
Both Visa and Mastercard are strong market players. And it is up to you to decide which one is a better buy now. In the long run, both seem to be a good way to invest.
The coronavirus pandemic is raging and there’s still no treatment or vaccine. Regardless, let’s look at the stocks of two major biotech companies: Gilead Sciences and Moderna.
Though now Moderna (MRNA) stock is significantly below its ATH, Oppenheimer analyst predicts an 80% increase from the current level.
Home Depot (HD) stock price fell as the company reported poor earnings due to extra costs related to the coronavirus pandemic. However, sales were stronger than expected.
Moderna (MRNA) stock is one of the biotech firms taking the lead in the current fight against COVID-19. The company could see fortunes change soon. Yesterday, MRNA gained over 10%, today in the pre-market, it is up another 3.89%.
Apple played a significant role in Monday’s historic rally. Shares of the iPhone maker soared 9.3%. It was the AAPL stock’s largest one-day move in more than 11 years.
As you may know, there is a number of corporations that are helping the United States look good in the minds of other countries. And Tesla is definitely one of them.
As the price for Tesla stock is moving higher, we can say that Elon Musk’s entrepreneurial streak is starting to pay off.
Bakkt platform was finally launched in September 2019 only to be greeted by a very lukewarm response from investors but analysts from Oppenheimer & Co think that it is too early to write it off.